Cargando…
The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
We investigated the effect of tofogliflozin, a sodium-dependent glucose cotransporter 2 inhibitor (SGLT2i), on retinal blood flow dysregulation, neural retinal dysfunction, and the impaired neurovascular coupling in type 2 diabetic mice. Tofogliflozin was added to mouse chow to deliver 5 mg/kg/day a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835894/ https://www.ncbi.nlm.nih.gov/pubmed/35163285 http://dx.doi.org/10.3390/ijms23031362 |
_version_ | 1784649544566308864 |
---|---|
author | Hanaguri, Junya Yokota, Harumasa Kushiyama, Akifumi Kushiyama, Sakura Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji |
author_facet | Hanaguri, Junya Yokota, Harumasa Kushiyama, Akifumi Kushiyama, Sakura Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji |
author_sort | Hanaguri, Junya |
collection | PubMed |
description | We investigated the effect of tofogliflozin, a sodium-dependent glucose cotransporter 2 inhibitor (SGLT2i), on retinal blood flow dysregulation, neural retinal dysfunction, and the impaired neurovascular coupling in type 2 diabetic mice. Tofogliflozin was added to mouse chow to deliver 5 mg/kg/day and 6-week-old mice were fed for 8 weeks. The longitudinal changes in the retinal neuronal function and blood flow responses to systemic hyperoxia and flicker stimulation were evaluated every 2 weeks in diabetic db/db mice that received tofogliflozin (n =6) or placebo (n = 6) from 8 to 14 weeks of age. We also evaluated glial activation and vascular endothelial growth factor (VEGF) expression by immunofluorescence. Tofogliflozin treatment caused a sustained decrease in blood glucose in db/db mice from 8 weeks of the treatment. In tofogliflozin-treated db/db mice, both responses improved from 8 to 14 weeks of age, compared with vehicle-treated diabetic mice. Subsequently, the electroretinography implicit time for the oscillatory potential was significantly improved in SGLT2i-treated db/db mice. The systemic tofogliflozin treatment prevented the activation of glial fibrillary acidic protein and VEGF protein expression, as detected by immunofluorescence. Our results suggest that glycemic control with tofogliflozin significantly improved the impaired retinal neurovascular coupling in type 2 diabetic mice with the inhibition of retinal glial activation. |
format | Online Article Text |
id | pubmed-8835894 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88358942022-02-12 The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice Hanaguri, Junya Yokota, Harumasa Kushiyama, Akifumi Kushiyama, Sakura Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji Int J Mol Sci Article We investigated the effect of tofogliflozin, a sodium-dependent glucose cotransporter 2 inhibitor (SGLT2i), on retinal blood flow dysregulation, neural retinal dysfunction, and the impaired neurovascular coupling in type 2 diabetic mice. Tofogliflozin was added to mouse chow to deliver 5 mg/kg/day and 6-week-old mice were fed for 8 weeks. The longitudinal changes in the retinal neuronal function and blood flow responses to systemic hyperoxia and flicker stimulation were evaluated every 2 weeks in diabetic db/db mice that received tofogliflozin (n =6) or placebo (n = 6) from 8 to 14 weeks of age. We also evaluated glial activation and vascular endothelial growth factor (VEGF) expression by immunofluorescence. Tofogliflozin treatment caused a sustained decrease in blood glucose in db/db mice from 8 weeks of the treatment. In tofogliflozin-treated db/db mice, both responses improved from 8 to 14 weeks of age, compared with vehicle-treated diabetic mice. Subsequently, the electroretinography implicit time for the oscillatory potential was significantly improved in SGLT2i-treated db/db mice. The systemic tofogliflozin treatment prevented the activation of glial fibrillary acidic protein and VEGF protein expression, as detected by immunofluorescence. Our results suggest that glycemic control with tofogliflozin significantly improved the impaired retinal neurovascular coupling in type 2 diabetic mice with the inhibition of retinal glial activation. MDPI 2022-01-25 /pmc/articles/PMC8835894/ /pubmed/35163285 http://dx.doi.org/10.3390/ijms23031362 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Hanaguri, Junya Yokota, Harumasa Kushiyama, Akifumi Kushiyama, Sakura Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice |
title | The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice |
title_full | The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice |
title_fullStr | The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice |
title_full_unstemmed | The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice |
title_short | The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice |
title_sort | effect of sodium-dependent glucose cotransporter 2 inhibitor tofogliflozin on neurovascular coupling in the retina in type 2 diabetic mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835894/ https://www.ncbi.nlm.nih.gov/pubmed/35163285 http://dx.doi.org/10.3390/ijms23031362 |
work_keys_str_mv | AT hanagurijunya theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT yokotaharumasa theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT kushiyamaakifumi theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT kushiyamasakura theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT watanabemasahisa theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT yamagamisatoru theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT nagaokataiji theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT hanagurijunya effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT yokotaharumasa effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT kushiyamaakifumi effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT kushiyamasakura effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT watanabemasahisa effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT yamagamisatoru effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice AT nagaokataiji effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice |